Riskpilot← Back to searchSign inGet full accessPharnordic AB
ABActiveOrg 5568875735Klintvägen 43Computer consultancy and computer facilities management activities · NACE 6220Est. 20120 employees
Revenue 2025
SEK 0
EBITDA margin
—
+25% vs 2024
Equity ratio
89.7%
Financial strength
Net profit 2025
SEK -3K
+25% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | +25% |
| Net profit | SEK -3K | +25% |
| Total assets | SEK 29K | -9% |
| Equity | SEK 26K | +4% |
| Employees | 0 | — |
Legal name
Pharnordic AB
Org number
5568875735
Legal form
Aktiebolag
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
14 mars 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet ska vara att bedriva handel med kosttillskott, naturmedel, läkemedel, medicinteknisk utrustning och kosmetik, samt bedriva annan därmed förenlig verksamhet
Address
Klintvägen 43
Email
yu.yang2001@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 1 050 | 331 | 20 | 65 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | — | — | −1 | −15 | 28 | −23 | −10 | −1 | −4 | −3 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | −1 | −15 | 28 | −23 | −10 | −1 | −4 | −3 |
| Net financials | — | — | — | — | — | — | — | — | — | — |
| Profit before tax | 0 | 0 | −1 | −15 | 28 | −23 | −10 | −1 | −4 | −3 |
| Tax | −0 | −0 | −0 | −0 | −3 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | −1 | −15 | 25 | −23 | −10 | −1 | −4 | −3 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 50 | 50 | 49 | 34 | 346 | 83 | 28 | 34 | 32 | 29 |
| Equity | 49 | 49 | 48 | 33 | 57 | 34 | 28 | 26 | 25 | 26 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 | 1 | 2 | 2 | 289 | 49 | 0 | 8 | 7 | 3 |
| Total debt | 1 | 1 | 2 | 2 | 289 | 49 | — | 8 | 7 | 3 |
EBITDA margin
-300000.0%
This company
15.8%
Market median
-1898834% vs market
20162025
Equity ratio
89.7%
This company
38.2%
Market median
+135% vs market
20162025
Return on equity
-11.5%
This company
18.4%
Market median
-163% vs market
20162025
Net profit margin
-300000.0%
This company
8.1%
Market median
-3703804% vs market
20162025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.